Buy Drug Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 11 Year, 4 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth -22.37%
- Profit Growth -27.98%
- Ebitda -25.20%
- Net Worth -77.76%
- Total Assets -55.78%
About Buy Drug
Buy Drug Private Limited (BDPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 October 2013 and has a history of 11 years and four months. Its registered office is in Delhi, India.
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Brijendra Kumar and Sudha Dwivedi serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74999DL2013PTC259076
-
Company No.
259076
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Oct 2013
-
Date of AGM
20 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Buy Drug?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Brijendra Kumar
|
Director | 16-Oct-2017 | Current |
|
Sudha Dwivedi
|
Director | 09-May-2016 | Current |
Financial Performance of Buy Drug.
Buy Drug Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 22.37% decrease. The company also saw a substantial fall in profitability, with a 27.98% decrease in profit. The company's net worth observed a substantial decline by a decrease of 77.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Buy Drug?
In 2017, Buy Drug had a promoter holding of 25.55% and a public holding of 74.45%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Buy Drug?
Unlock and access historical data on people associated with Buy Drug, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Buy Drug, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Buy Drug's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
